IMMUNE CHECKPOINT INHIBITORS
Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management
Citing previous published reports and current evidence, this review article focuses on the incidence, diagnosis, clinical manifestations, underlying mechanisms, treatments, outcomes, and possible management strategies of cardiotoxicity associated with immune checkpoint inhibitor (ICI) therapy.
Frontiers in PharmacologyMeet the Faculty
Videos
-
Immune Checkpoint Inhibitors Managing Cardiotoxicity Associated With Immune Checkpoint Inhibitor Therapy
-
Immune Checkpoint Inhibitors Immune Checkpoint Inhibitors and Cardiotoxicity: Incidence and Patient Risk Factors
-
Immune Checkpoint Inhibitors Immune Checkpoint Inhibitors and Cardiotoxicity: The Pharmacist Perspective
